chrX-110200997-C-A

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4BS2

The NM_015365.3(AMMECR1):​c.844G>T​(p.Ala282Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000146 in 1,095,066 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 6 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 22)
Exomes 𝑓: 0.000015 ( 0 hom. 6 hem. )

Consequence

AMMECR1
NM_015365.3 missense

Scores

3
3
11

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 7.57

Publications

1 publications found
Variant links:
Genes affected
AMMECR1 (HGNC:467): (AMMECR nuclear protein 1) The exact function of this gene is not known, however, submicroscopic deletion of the X chromosome including this gene, COL4A5, and FACL4 genes, result in a contiguous gene deletion syndrome, the AMME complex (Alport syndrome, mental retardation, midface hypoplasia, and elliptocytosis). Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2010]
AMMECR1 Gene-Disease associations (from GenCC):
  • midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis
    Inheritance: XL Classification: STRONG, MODERATE Submitted by: Illumina, Labcorp Genetics (formerly Invitae)
  • Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndrome
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.35056674).
BS2
High Hemizygotes in GnomAdExome4 at 6 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AMMECR1NM_015365.3 linkc.844G>T p.Ala282Ser missense_variant Exon 5 of 6 ENST00000262844.10 NP_056180.1
AMMECR1NM_001025580.2 linkc.733G>T p.Ala245Ser missense_variant Exon 4 of 5 NP_001020751.1
AMMECR1NM_001171689.2 linkc.475G>T p.Ala159Ser missense_variant Exon 7 of 8 NP_001165160.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AMMECR1ENST00000262844.10 linkc.844G>T p.Ala282Ser missense_variant Exon 5 of 6 1 NM_015365.3 ENSP00000262844.5 Q9Y4X0-1

Frequencies

GnomAD3 genomes
Cov.:
22
GnomAD2 exomes
AF:
0.0000110
AC:
2
AN:
182522
AF XY:
0.0000149
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000245
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000146
AC:
16
AN:
1095066
Hom.:
0
Cov.:
27
AF XY:
0.0000166
AC XY:
6
AN XY:
361202
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26294
American (AMR)
AF:
0.00
AC:
0
AN:
35152
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19311
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30175
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54043
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40268
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4119
European-Non Finnish (NFE)
AF:
0.0000191
AC:
16
AN:
839733
Other (OTH)
AF:
0.00
AC:
0
AN:
45971
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.420
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
22
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Dec 11, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.844G>T (p.A282S) alteration is located in exon 5 (coding exon 5) of the AMMECR1 gene. This alteration results from a G to T substitution at nucleotide position 844, causing the alanine (A) at amino acid position 282 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.21
BayesDel_addAF
Uncertain
0.045
T
BayesDel_noAF
Benign
-0.12
CADD
Benign
22
DANN
Uncertain
0.99
DEOGEN2
Benign
0.24
T;.;.
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Pathogenic
0.97
D;D;D
M_CAP
Uncertain
0.17
D
MetaRNN
Benign
0.35
T;T;T
MetaSVM
Benign
-0.78
T
MutationAssessor
Benign
1.7
L;.;.
PhyloP100
7.6
PrimateAI
Pathogenic
0.82
D
PROVEAN
Benign
-1.1
N;N;N
REVEL
Benign
0.25
Sift
Benign
0.095
T;T;T
Sift4G
Benign
0.16
T;T;T
Polyphen
0.21
B;B;.
Vest4
0.60
MutPred
0.52
Gain of disorder (P = 0.0254);.;.;
MVP
0.50
MPC
0.69
ClinPred
0.39
T
GERP RS
6.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.19
gMVP
0.84
Mutation Taster
=47/53
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1241624179; hg19: chrX-109444225; API